Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Research Suggests Proton Pump Inhibitors May Help Limit Fibrosis in Eosinophilic Esophagitis
Research with Phoenix Children’s pediatric gastroenterologist Colby S. Sharlin, MD, as first author suggests PPIs may help limit scarring in eosinophilic esophagitis, not just inflammation.
Research led by Colby S. Sharlin, MD, found that proton pump inhibitors may have anti-fibrotic effects in eosinophilic esophagitis (EoE), in clinical cohorts and basic science experiments.
2
Fibrosis is the main driver of EoE complications and may progress to esophageal strictures, which can impair quality of life and require dilation.
3
Choking and food impaction may signal fibrosis, while endoscopy can show narrowing, strictures, or rings and biopsy can detect microscopic scarring.
4
PPI treatment decisions at Phoenix Children’s involve shared decision-making and consideration of each child’s medical history, nutritional status, and ability to take medication orally.
5
Follow-up evaluation, typically with sedated upper endoscopy, is needed to assess treatment response; sedation-free monitoring options include transnasal endoscopy and the esophageal string test.